The Department of Defense is funding research being carried out by the Larner College of Medicine and UVM Medical Center into ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

The story of Hamilton County is the story of much of America in 2025. Overdose deaths have fallen sharply, offering hope the ...

US President Donald Trump yesterday ordered 25% tariffs on Canadian and Mexican imports – lumping a 10% tax rate on goods from China as well saying Beijing needed to stanch the flow of fentanyl, a ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.